Charles Schwab
BHC icon

Charles Schwab’s Bausch Health BHC Stock Holding History

Charles Schwab’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Sell
2,186,244
-23,323
-1% -$125K ﹤0.01% 2121
2026
Q1 		$11.9M Buy
2,209,567
+163,830
+8% +$980K ﹤0.01% 2022
2025
Q4 		$14.2M Buy
2,045,737
+151,658
+8% +$997K ﹤0.01% 1956
2025
Q3 		$12.2M Buy
1,894,079
+287,033
+18% +$1.96M ﹤0.01% 2018
2025
Q2 		$10.7M Buy
1,607,046
+265,047
+20% +$1.36M ﹤0.01% 1981
2025
Q1 		$8.7M Buy
1,341,999
+57,963
+5% +$416K ﹤0.01% 2016
2024
Q4 		$10.4M Buy
1,284,036
+14,558
+1% +$120K ﹤0.01% 1995
2024
Q3 		$10.4M Buy
1,269,478
+42,539
+3% +$280K ﹤0.01% 2011
2024
Q2 		$8.55M Buy
+1,226,939
New +$9.28M ﹤0.01% 2122
2015
Q4 		– Sell
-61,957
Closed -$11.1M – 3104
2015
Q3 		$11.1M Sell
61,957
-16,400
-21% -$3.82M 0.02% 931
2015
Q2 		$17.4M Buy
78,357
+9,100
+13% +$2.02M 0.02% 638
2015
Q1 		$13.8M Buy
+69,257
New +$12.3M 0.02% 780

Other funds holding BHC

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Charles Schwab's BHC Position: Q2 2026 in Review

Charles Schwab reduced its Bausch Health (BHC) stake by 1.1% in Q2 2026, selling an estimated $125K and leaving 2,186,244 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

Charles Schwab first reported a position in BHC in Q1 2015 and has held it in 12 quarters since. The position peaked at $17.4M in Q2 2015. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Charles Schwab held 2,186,244 shares of Bausch Health worth $10.8M as of Q2 2026.
  • Charles Schwab sold 23,323 Bausch Health shares in Q2 2026, an estimated $125K.
  • Bausch Health made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2121 holding.
  • Charles Schwab first reported a position in Bausch Health in Q1 2015 and has held it in 12 quarters since.
  • Charles Schwab's Bausch Health position peaked at $17.4M in Q2 2015.
  • 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.